financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Adss Of Alibaba Group Holding Limited
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Adss Of Alibaba Group Holding Limited
May 14, 2024 9:12 AM

11:50 AM EDT, 05/14/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our 12-month target at USD87, on a P/E of 9.6x our FY 25 (Mar.) view, below peers/historical. We reduce our FY 25 earnings per ADS view to CNY59.70 from CNY68.15 and FY 26 to CNY66.63 from CNY70.81. BABA posted Mar-Q earnings per ADS of CNY10.14 vs. CNY10.71, missing the CNY10.24 consensus. Sales rose 6.6%, slightly above expectations on international E-commerce Expansion (+45%), Logistics (+30%), and Local Services (+19%). We remain disappointed by anemic growth from Taobao/Tmall (+4%) and Cloud (+3%), 54% of sales combined. That said, BABA cited that cloud could return to double-digit growth in 2H of FY 25, excluding internal customers. We like the greater cash return to investors and the robust balance sheet (net cash of $61.8B), but expect margins to remain pressured due to more elevated investments to try to reinvigorate growth into E-commerce/Cloud. Still, we remain hesitant about prospects given pricing/competitive pressures, geopolitical uncertainty, and limited access to advanced chips.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Oct 8, 2025
01:40 PM EDT, 10/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Pfizer Inc. (PFE 26 ****) and the U.S. government struck the first Most Favored Nation (MFN) drug pricing deal to lower drug prices in the U.S., we see policy...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Oct 7, 2025
11:50 AM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $10 to $175, based on a 2027 P/E of 13.7x, a steep but justified discount to STZ's 10-year average forward P/E of 21.6x. We...
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Oct 7, 2025
02:30 PM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $1 to $59, about 19x our FY 26 (Nov.) EPS estimate of $3.12 (down from $3.14; FY 25 raised to $3.03 from $2.97). This...
Research Alert: CFRA Lowers Opinion On Lucid Group Inc. Shares To Strong Sell From Sell
Research Alert: CFRA Lowers Opinion On Lucid Group Inc. Shares To Strong Sell From Sell
Oct 7, 2025
08:20 AM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target of $10. We lower our adjusted EPS estimates to -$11.15 from -$10.50 for 2025 and to -$11.50 from -$11.00 for 2026. LCID posted Q3 vehicle...
Copyright 2023-2026 - www.financetom.com All Rights Reserved